Objective: Uterine transposition has emerged as an alternative for fertility preservation in women with pelvic malignancies that require radiotherapy. The goal of this study was to evaluate the short-term outcomes of patients undergoing uterine transposition after trachelectomy for cervical cancer or before chemoradiation for vaginal cancer.
Methods: We retrospectively evaluated patients with early stage cervical cancer after radical trachelectomy or with vaginal cancer with indication for pelvic radiation who had uterine transposition performed as fertility sparing strategy.
Results: Four patients with cervical cancer and one patient with vaginal cancer were included. Median age was 32 years (range 28-38). All patients had squamous cell carcinomas. All patients with cervical cancer had radical trachelectomies with sentinel lymph node dissection (SLN). Two of these patients also had pelvic lymphadenectomies. Indications for adjuvant radiotherapy was due to Sedlis criteria in two patients and to lymph node metastasis in the other two patients. The patient with stage IIB vaginal cancer was recommended primary chemoradiation. All patients underwent uterine transposition before radiotherapy. The median uterine transposition surgical time was 90 min (range 80-205) and no early complications (30 days) occurred. Average time from uterine transposition to start of radiotherapy was 16 days (10-28). After radiation, the uterus along with the ovaries and tubes were repositioned and the residual cervix sutured to the vagina. One patient declined uterine reimplantation after radiation and underwent a hysterectomy. After a median follow-up of 25 months (range 1-30), all patients were without evidence of disease. All patients with preserved uterus have normal menses after treatment. One patient has attempted to conceive with IVF techniques without success.
Conclusions: Uterine transposition may be an option in selected patients with cervical and vaginal cancers who want to preserve fertility. However, further studies that address its oncological safety and obstetrical outcomes are encouraged.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1136/ijgc-2020-001780 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Post-radical hysterectomy ovarian torsion-A gynecological emergency: a case series.
J Med Case Rep
December 2024
Consultant Gynaecology Oncologist, Royal Sussex Hospital, Brighton, UK.
Article Synopsis
- * The report highlighted two cases of ovarian torsion following laparoscopic radical hysterectomy for cervical cancer, where both patients underwent a procedure meant to prevent this complication but still experienced torsion.
- * With ovarian torsion occurring in 1-8% of post-hysterectomy cases and rising cervical cancer rates among younger women, further research and improved surgical techniques are essential for better prevention and diagnosis.
Transverse testicular ectopia in a newborn with transposition of the great arteries: A unique case report.
Int J Surg Case Rep
November 2024
The Queensland Children's Hospital, 501 Stanley Street, South Brisbane, QLD 4101, Australia; The University of Queensland, St Lucia, QLD 4072, Australia.
Article Synopsis
- Transverse testicular ectopia (TTE) is a rare congenital condition where both testes and parts of Müllerian organs herniate into a single passage in males with a 46XY karyotype, and it’s often associated with persistent Müllerian duct syndrome (PMDS).
- The case highlights a 3-day-old newborn male with TTE and a concurrent heart issue called transposition of the great arteries (TGA), where a postnatal ultrasound raised concerns about variations in sexual characteristics.
- This case is significant as it's the first documented instance of TGA occurring alongside TTE, emphasizing the need for careful diagnosis and interdisciplinary care for optimal outcomes in such rare congenital anomalies.
As oncologic therapy continues to advance, survivorship care has widened the realm of possibilities for quality-of-life improvements, including fertility preservation and restoration. We aim to summarize the current and future directions of fertility preservation techniques for patients facing gonadotoxic medical therapies who desire pregnancy after their condition is treated. This review of both ovarian and uterine transposition highlights the present roles, techniques, and fertility outcomes of the two fertility preservation treatment modalities designed to protect reproductive organs from harmful pelvic radiation.
View Article and Find Full Text PDFFirst birth after uterine transposition in low-volume lymph node metastasis of cervical cancer: A long journey for success.
J Surg Oncol
September 2024
Department of Gynecological Oncology, Hospital Erasto Gaertner, Curitiba, Brazil.
Locally advanced cervical cancer poses a significant challenge to fertility-sparing treatments. Pelvic radiotherapy impairs reproductive potential owing to ovarian, uterine, and endometrial side effects. This study presents a literature review of the main fertility-sparing therapeutic alternatives for locally advanced cervical cancer and a case report of the first childbirth following uterine transposition for gynecological malignancies.
View Article and Find Full Text PDFUterine Transposition.
Ann Surg Oncol
October 2024
Gynecology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
In this video, we review the steps of uterine transposition, emphasizing robotic trocar placement and docking, how to optimize organ manipulation and tissue handling, and our pearls for successful perioperative management. The patient is a 27-year-old woman with T2 node-positive rectal cancer. Uterine transposition is a new surgical procedure with limited information regarding outcomes.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!